Orchard Therapeutics plc - ADR
ORTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$380.11M
Close$
$17.15
2.7% upside
Current Fair Value
2.7% upsideUndervalued by 2.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $380.11 Million |
|---|---|
| Enterprise Value | $405.20 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.61 |
| Beta | 0.55 |
| Outstanding Shares | 22,838,856 |
Return
| Return on Equity | 87.04% |
|---|---|
| Return on Assets | 34.54% |
| Return on Invested Capital | 40.55% |
Valuation & Multiples
| P/E Ratio | -27.11 |
|---|---|
| PEG | 105.3 |
| Price to Sales | - |
| Price to Book Ratio | 5.57 |
| Enterprise Value to Revenue | 18.55 |
| Enterprise Value to EBIT | 6.54 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.61 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data